Sujal Shah
CIK 1588861 · Chief Executive Officer · last filed 2026-06-11
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
2
Total Filings
35
Lifetime Open-Market Net
-$2.62M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TVRD | Director | — | $2.64 | — | $0 | 2 | 2026-06-11 |
| CymaBay Therapeutics, Inc. (CBAY) Delisted | Chief Executive Officer | 0 | $32.48 | $0 | -$2.62M | 30 | 2024-03-22 |
Recent Filings · Page 3 of 4
35 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-05-15 | CymaBay Therapeutics, Inc. (CBAY) Delisted | Buy (P) | +5,000 | $53.2K | EDGAR |
| 2018-01-26 | CymaBay Therapeutics, Inc. (CBAY) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-10-31 | CymaBay Therapeutics, Inc. (CBAY) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-07-24 | CymaBay Therapeutics, Inc. (CBAY) Delisted | Buy (P) | +10,000 | $73.4K | EDGAR |
| 2017-05-01 | CymaBay Therapeutics, Inc. (CBAY) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-01-23 | CymaBay Therapeutics, Inc. (CBAY) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-01-06 | CymaBay Therapeutics, Inc. (CBAY) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-01-04 | CymaBay Therapeutics, Inc. (CBAY) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-04-06 | CymaBay Therapeutics, Inc. (CBAY) Delisted | Buy (P) | +55,000 | $76.5K | EDGAR |
| 2016-01-28 | CymaBay Therapeutics, Inc. (CBAY) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.